Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-08-22

FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LIALDA (mesalamine) from Takeda Pharmaceuticals America, Inc. This approval results in changes to the product's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIALDA (mesalamine)

Snippet

SUPPL AP for LIALDA (MESALAMINE)